Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial
Kazaks AG, Uriu-Adams JY, Albertson TE
Published in Journal of Asthma, Vol. 47 (1), pp. 83-92
Methodology
Randomised double-blind placebo-controlled trial of oral magnesium 340 mg/day for 6.5 months in mild-to-moderate asthma.
Key Findings
Oral magnesium improved methacholine-measured airway reactivity and asthma control and quality of life scores versus placebo.
Conclusions
Oral magnesium may modestly improve airway reactivity in mild asthma.
Limitations
Small single-centre trial; multiple outcome measures.
Supplements Studied
Oral magnesium improved methacholine-measured airway reactivity and asthma control.
Outcomes Measured
Oral magnesium improved methacholine-measured airway reactivity and asthma control.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.